General
Preferred name
MIFAMURTIDE
Synonyms
MIFAMURTIDE SODIUM HYDRATE ()
Junovan ()
CGP 19835 ()
MTP-PE ()
L-MTP-PE ()
Mifamurtide ()
CGP-19835 ()
Mifamurtide sodium hydrate ()
Sodium mifamurtide ()
Mifamurtide sodium salt monohydrate ()
P&D ID
PD071888
CAS
90825-43-7
Tags
natural product
drug
available
Approved by
EMA
First approval
2009
Drug Status
approved
Max Phase
Phase 4
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
6
ChEMBL Approved Drugs
ChEMBL Drugs
DrugCentral
DrugCentral Approved Drugs
Natural product-based probes and drugs
ReFrame library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
18
Properties
(calculated by RDKit )
Molecular Weight
1236.75
Hydrogen Bond Acceptors
18
Hydrogen Bond Donors
10
Rotatable Bonds
52
Ring Count
1
Aromatic Ring Count
0
cLogP
5.76
TPSA
376.1
Fraction CSP3
0.86
Chiral centers
11.0
Largest ring
6.0
QED
0.02
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Biosynthetic Origin
Peptide (NRPS), Fatty Acid
Therapeutic Indication
Anticancer
Source data
